1. Home
  2. WH vs GRFS Comparison

WH vs GRFS Comparison

Compare WH & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WH
  • GRFS
  • Stock Information
  • Founded
  • WH 2017
  • GRFS 1940
  • Country
  • WH United States
  • GRFS Spain
  • Employees
  • WH N/A
  • GRFS N/A
  • Industry
  • WH Hotels/Resorts
  • GRFS Biotechnology: Pharmaceutical Preparations
  • Sector
  • WH Consumer Discretionary
  • GRFS Health Care
  • Exchange
  • WH Nasdaq
  • GRFS Nasdaq
  • Market Cap
  • WH 5.8B
  • GRFS 6.6B
  • IPO Year
  • WH N/A
  • GRFS 2006
  • Fundamental
  • Price
  • WH $78.41
  • GRFS $9.65
  • Analyst Decision
  • WH Strong Buy
  • GRFS Hold
  • Analyst Count
  • WH 11
  • GRFS 1
  • Target Price
  • WH $104.98
  • GRFS $10.30
  • AVG Volume (30 Days)
  • WH 774.3K
  • GRFS 511.4K
  • Earning Date
  • WH 10-22-2025
  • GRFS 01-01-0001
  • Dividend Yield
  • WH 2.10%
  • GRFS 1.48%
  • EPS Growth
  • WH 38.05
  • GRFS 132.60
  • EPS
  • WH 4.27
  • GRFS 0.53
  • Revenue
  • WH $1,448,000,000.00
  • GRFS $8,744,226,659.00
  • Revenue This Year
  • WH $7.83
  • GRFS $5.46
  • Revenue Next Year
  • WH $5.94
  • GRFS $6.69
  • P/E Ratio
  • WH $18.33
  • GRFS $24.36
  • Revenue Growth
  • WH 4.32
  • GRFS 9.32
  • 52 Week Low
  • WH $75.29
  • GRFS $6.19
  • 52 Week High
  • WH $113.07
  • GRFS $11.14
  • Technical
  • Relative Strength Index (RSI)
  • WH 40.44
  • GRFS 46.87
  • Support Level
  • WH $77.05
  • GRFS $9.39
  • Resistance Level
  • WH $79.32
  • GRFS $9.86
  • Average True Range (ATR)
  • WH 1.87
  • GRFS 0.20
  • MACD
  • WH 0.01
  • GRFS 0.00
  • Stochastic Oscillator
  • WH 47.78
  • GRFS 41.41

About WH Wyndham Hotels & Resorts Inc.

As of June 30, 2025, Wyndham Hotels & Resorts operates 846,700 rooms across more than 20 brands predominantly in the economy and midscale segments. Super 8 is the largest brand, representing around 18% of all rooms, with Days Inn (13%) and Ramada (14%) the next two largest brands, as of the end of 2024. During the past several years, the company has expanded its extended stay/lifestyle brands, which appeal to travelers seeking to experience the local culture of a given location. The company closed its La Quinta acquisition in the second quarter of 2018, adding around 90,000 rooms at the time the deal closed. Wyndham launched a new extended stay economy scale segment concept, ECHO, in the spring of 2022. The United States represents 56% of total rooms, as of the end of 2024.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: